{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:34:34Z","timestamp":1791592474497,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jcin.2024.08.050","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T14:18:51Z","timestamp":1736777931000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5409-1943","authenticated-orcid":false,"given":"David A.","family":"Power","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Camaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Kereiakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2425-2005","authenticated-orcid":false,"given":"Runlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-2202","authenticated-orcid":false,"given":"Kelly A.","family":"Stockelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ovidiu","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Onuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcin.2024.08.050_bib1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jcin.2024.08.050_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCINTERVENTIONS.112.000248","article-title":"Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents","volume":"6","author":"Ali","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.jcin.2024.08.050_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","article-title":"Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium Xience V stent in a porcine coronary artery model","volume":"7","author":"Otsuka","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.jcin.2024.08.050_bib4","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jcin.2015.02.029","article-title":"Incidence and clinical impact of stent fracture after PROMUS Element platinum chromium everolimus-eluting stent implantation","volume":"8","author":"Kuramitsu","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jcin.2024.08.050_bib5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.116.021539","article-title":"Bioresorbable vascular scaffolds for coronary revascularization","volume":"134","author":"Kereiakes","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.08.050_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2022.05.024","article-title":"Bioresorbable stents: is the game over?","volume":"361","author":"Gallinoro","year":"2022","journal-title":"Int J Cardiol"},{"issue":"22","key":"10.1016\/j.jcin.2024.08.050_bib7","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.109.921528","volume":"122","author":"Onuma","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.jcin.2024.08.050_bib8","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamacardio.2019.4101","article-title":"Time-varying outcomes with the absorb bioresorbable vascular scaffold during 5-year follow-up: a systematic meta-analysis and individual patient data pooled study","volume":"4","author":"Stone","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.jcin.2024.08.050_bib9","first-page":"179","article-title":"Challenges of the newer generation of resorbable magnesium scaffolds: lessons from failure mechanisms of the past generation","volume":"81","author":"Seguchi","year":"2023","journal-title":"J\u00a0Cardiol"},{"issue":"10157","key":"10.1016\/j.jcin.2024.08.050_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0140-6736(18)32283-9","article-title":"Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the Absorb IV randomised trial","volume":"392","author":"Stone","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jcin.2024.08.050_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jacc.2023.05.003","article-title":"5-Year outcomes after bioresorbable coronary scaffolds implanted with improved technique","volume":"82","author":"Stone","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jcin.2024.08.050_bib12","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.jcin.2024.08.050_bib13","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB CHINA trial","volume":"66","author":"Gao","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jcin.2024.08.050_bib14","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-Year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jcin.2024.08.050_bib15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1253\/circj.CJ-19-1184","article-title":"Long-term outcomes of Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent\u2014a randomized comparison through 5 years in Japan","volume":"84","author":"Kozuma","year":"2020","journal-title":"Circ J"},{"issue":"11","key":"10.1016\/j.jcin.2024.08.050_bib16","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.4244\/EIJ-D-20-00024","article-title":"Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial","volume":"16","author":"Onuma","year":"2020","journal-title":"EuroIntervention"},{"issue":"9962","key":"10.1016\/j.jcin.2024.08.050_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"issue":"13 suppl","key":"10.1016\/j.jcin.2024.08.050_bib18","article-title":"TCT-47 5-year clinical outcomes from randomized comparison of everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with coronary artery disease from ABSORB CHINA trial","volume":"74","author":"Gao","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jcin.2024.08.050_bib19","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1161\/CIRCULATIONAHA.119.042584","article-title":"Clinical outcomes before and after complete everolimus-eluting bioresorbable scaffold resorption: five-year follow-up from the ABSORB III trial","volume":"140","author":"Kereiakes","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2024.08.050_bib20","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.jcin.2024.08.050_bib21","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jcin.2024.08.050_bib22","first-page":"523","article-title":"Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"99","author":"Schukraft","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.jcin.2024.08.050_bib23","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2015.08.863","article-title":"Very late thrombosis after bioresorbable scaffolds: cause for concern?","volume":"66","author":"Stone","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jcin.2024.08.050_bib24","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/j.jcin.2016.09.037","article-title":"Malabsorption of a bioresorbable vascular scaffold system leading to very late in-scaffold restenosis more than 3.5 years after implantation","volume":"9","author":"Dommasch","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"33","key":"10.1016\/j.jcin.2024.08.050_bib25","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1093\/eurheartj\/ehx358","article-title":"Non-Newtonian pulsatile shear stress assessment: a method to differentiate bioresorbable scaffold platforms","volume":"38","author":"Tenekecioglu","year":"2017","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.jcin.2024.08.050_bib26","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.jacc.2017.09.1106","article-title":"Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials","volume":"70","author":"Stone","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2024.08.050_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2305637","article-title":"Drug-eluting resorbable scaffold versus angioplasty for infrapopliteal artery disease","volume":"390","author":"Varcoe","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.jcin.2024.08.050_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17434440.2021.1904894","article-title":"Current perspectives on bioresorbable scaffolds in coronary intervention and other fields","volume":"18","author":"Wu","year":"2021","journal-title":"Exp Rev Med Devices"},{"issue":"5","key":"10.1016\/j.jcin.2024.08.050_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013302","article-title":"Drug-coated balloons in the management of coronary artery disease","volume":"17","author":"Korjian","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.jcin.2024.08.050_bib30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.2024.1361","article-title":"Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial","volume":"331","author":"Yeh","year":"2024","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.jcin.2024.08.050_bib31","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4244\/EIJ-D-21-00419","article-title":"Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial","volume":"17","author":"Kerkmeijer","year":"2022","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.jcin.2024.08.050_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/14779072.2018.1523718","article-title":"Optimal duration of dual antiplatelet therapy after PCI: integrating procedural complexity, bleeding risk and the acuteness of clinical presentation","volume":"16","author":"Chen","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"12","key":"10.1016\/j.jcin.2024.08.050_bib33","doi-asserted-by":"crossref","first-page":"e981","DOI":"10.4244\/EIJ-D-21-00263","article-title":"Optimal dual antiplatelet therapy duration for bioresorbable scaffolds: an individual patient data pooled analysis of the ABSORB trials","volume":"17","author":"Azzalini","year":"2021","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.jcin.2024.08.050_bib34","first-page":"48","article-title":"Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance","volume":"97","author":"Costantini","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.jcin.2024.08.050_bib35","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.4244\/EIJ-D-16-00247","article-title":"Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy","volume":"12","author":"Tanaka","year":"2017","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.jcin.2024.08.050_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008383","article-title":"Optical coherence tomography for coronary bioresorbable vascular scaffold implantation","volume":"13","author":"Lee","year":"2020","journal-title":"Circ Cardiovasc Interv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824012779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879824012779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:15:02Z","timestamp":1768270502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879824012779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1936879824012779"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2024.08.050","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2024.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}